On March 13th 2018, Dr Kathy Liddell (LML Director) participated in "Genome editing: how far should we go?", a panel discussion event organised by the Babraham Institute as part of the Cambridge Science Festival.
The genome editing technique CRISPR/Cas9 has revolutionised biological and medical research. In this panel discussion, the risks and opportunities of this technique were explored from the different perspectives of a scientist, a research funding organisation, a regulatory body, a bioethicist, a patient representative and a citizen representative.
The event sought to encourage wide and active discussion. A more participatory approach to research is a new strategy of the European Commission known as Open Science. In return, making research more participatory and transparent seeks to improve research quality, impact and competitiveness.
The Babraham Institute organised this event as a part of the European funded project ORION. ORION seeks to implement Open Science and Responsible Research and Innovation in research funding and performing organisations.